Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
S. Cao, E. Budina, M. M. Raczy…·J. A. Hubbell
This study develops a butyrate prodrug, SerBut, which improves oral bioavailability and reduces autoimmune arthritis and neuroinflammation in mouse models.
R. P. Wallace, K. C. Refvik, J. T. Antane…·J. A. Hubbell
This study shows that conjugating immunogenic biologics to a synthetic mannose polymer reduces anti-drug antibody responses by impairing T cell and B cell responses.
M. J. V. WHITE, M. Raczy, E. Budina…·J. Hubbell
This study develops collagen-targeted therapeutics that reduce lung and kidney fibrosis in mice by improving drug delivery and efficacy.
L. R. Volpatti, R. P. Wallace, S. Cao…·J. Hubbell
This study develops a subunit nanovaccine using polymersomes decorated with SARS-CoV-2 RBD, showing enhanced neutralizing antibody and T cell responses in mice.
M. WHITE, m. ozkan, J. E. G. Medellin…·J. A. Hubbell
Blocking antibodies against integrins-3, -M, and -Mβ2 reverse lung and kidney fibrosis in a mouse model by de-differentiating myofibroblasts.
L. T. Gray, M. M. Raczy, P. S. Briquez…·J. A. Hubbell
This paper demonstrates that conjugating the SARS-CoV-2 Spike protein to a polymeric glyco-adjuvant elicits strong cellular and humoral immune responses in mice.